nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—PTGS2—ovarian follicle—polycystic ovary syndrome	0.0466	0.135	CbGeAlD
Pomalidomide—TNF—vagina—polycystic ovary syndrome	0.0265	0.0768	CbGeAlD
Pomalidomide—CYP1A2—urine—polycystic ovary syndrome	0.0235	0.0681	CbGeAlD
Pomalidomide—CRBN—embryo—polycystic ovary syndrome	0.0231	0.067	CbGeAlD
Pomalidomide—CRBN—adrenal cortex—polycystic ovary syndrome	0.0189	0.0549	CbGeAlD
Pomalidomide—CYP3A4—urine—polycystic ovary syndrome	0.017	0.0493	CbGeAlD
Pomalidomide—CRBN—endometrium—polycystic ovary syndrome	0.0169	0.049	CbGeAlD
Pomalidomide—CRBN—uterus—polycystic ovary syndrome	0.0156	0.0452	CbGeAlD
Pomalidomide—CRBN—pituitary gland—polycystic ovary syndrome	0.0153	0.0443	CbGeAlD
Pomalidomide—CRBN—adipose tissue—polycystic ovary syndrome	0.0152	0.0442	CbGeAlD
Pomalidomide—CRBN—adrenal gland—polycystic ovary syndrome	0.0137	0.0396	CbGeAlD
Pomalidomide—CRBN—female gonad—polycystic ovary syndrome	0.0128	0.0369	CbGeAlD
Pomalidomide—CRBN—vagina—polycystic ovary syndrome	0.0127	0.0367	CbGeAlD
Pomalidomide—CRBN—endocrine gland—polycystic ovary syndrome	0.0119	0.0344	CbGeAlD
Pomalidomide—Neuropathy—Metformin—polycystic ovary syndrome	0.00664	0.0537	CcSEcCtD
Pomalidomide—PTGS2—embryo—polycystic ovary syndrome	0.0063	0.0182	CbGeAlD
Pomalidomide—Thalidomide—CYP1A1—polycystic ovary syndrome	0.00619	1	CrCbGaD
Pomalidomide—PTGS2—adrenal cortex—polycystic ovary syndrome	0.00516	0.0149	CbGeAlD
Pomalidomide—Pain in extremity—Metformin—polycystic ovary syndrome	0.00514	0.0415	CcSEcCtD
Pomalidomide—Dehydration—Metformin—polycystic ovary syndrome	0.00478	0.0386	CcSEcCtD
Pomalidomide—Breast disorder—Metformin—polycystic ovary syndrome	0.00464	0.0375	CcSEcCtD
Pomalidomide—PTGS2—endometrium—polycystic ovary syndrome	0.00461	0.0133	CbGeAlD
Pomalidomide—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00459	0.0371	CcSEcCtD
Pomalidomide—PTGS2—uterus—polycystic ovary syndrome	0.00425	0.0123	CbGeAlD
Pomalidomide—PTGS2—pituitary gland—polycystic ovary syndrome	0.00417	0.0121	CbGeAlD
Pomalidomide—PTGS2—adipose tissue—polycystic ovary syndrome	0.00415	0.012	CbGeAlD
Pomalidomide—Neutropenia—Metformin—polycystic ovary syndrome	0.00415	0.0336	CcSEcCtD
Pomalidomide—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00412	0.0334	CcSEcCtD
Pomalidomide—Infestation—Metformin—polycystic ovary syndrome	0.00396	0.032	CcSEcCtD
Pomalidomide—Infestation NOS—Metformin—polycystic ovary syndrome	0.00396	0.032	CcSEcCtD
Pomalidomide—CYP1A2—endocrine gland—polycystic ovary syndrome	0.0039	0.0113	CbGeAlD
Pomalidomide—ABCB1—embryo—polycystic ovary syndrome	0.00389	0.0113	CbGeAlD
Pomalidomide—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00388	0.0314	CcSEcCtD
Pomalidomide—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00374	0.0303	CcSEcCtD
Pomalidomide—PTGS2—adrenal gland—polycystic ovary syndrome	0.00372	0.0108	CbGeAlD
Pomalidomide—Oedema peripheral—Metformin—polycystic ovary syndrome	0.0035	0.0283	CcSEcCtD
Pomalidomide—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00349	0.0282	CcSEcCtD
Pomalidomide—PTGS2—female gonad—polycystic ovary syndrome	0.00347	0.0101	CbGeAlD
Pomalidomide—PTGS2—vagina—polycystic ovary syndrome	0.00345	0.01	CbGeAlD
Pomalidomide—Cardiac disorder—Metformin—polycystic ovary syndrome	0.0033	0.0267	CcSEcCtD
Pomalidomide—PTGS2—endocrine gland—polycystic ovary syndrome	0.00323	0.00935	CbGeAlD
Pomalidomide—Angiopathy—Metformin—polycystic ovary syndrome	0.00322	0.0261	CcSEcCtD
Pomalidomide—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.0032	0.0259	CcSEcCtD
Pomalidomide—ABCB1—adrenal cortex—polycystic ovary syndrome	0.00319	0.00924	CbGeAlD
Pomalidomide—Chills—Metformin—polycystic ovary syndrome	0.00319	0.0258	CcSEcCtD
Pomalidomide—Malnutrition—Metformin—polycystic ovary syndrome	0.00309	0.025	CcSEcCtD
Pomalidomide—Muscle spasms—Metformin—polycystic ovary syndrome	0.00297	0.0241	CcSEcCtD
Pomalidomide—Tremor—Metformin—polycystic ovary syndrome	0.0029	0.0234	CcSEcCtD
Pomalidomide—ABCB1—endometrium—polycystic ovary syndrome	0.00285	0.00825	CbGeAlD
Pomalidomide—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00282	0.00817	CbGeAlD
Pomalidomide—ABCB1—uterus—polycystic ovary syndrome	0.00263	0.00761	CbGeAlD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00261	0.0212	CcSEcCtD
Pomalidomide—ABCB1—pituitary gland—polycystic ovary syndrome	0.00258	0.00747	CbGeAlD
Pomalidomide—ABCB1—adipose tissue—polycystic ovary syndrome	0.00257	0.00744	CbGeAlD
Pomalidomide—Infection—Metformin—polycystic ovary syndrome	0.00251	0.0203	CcSEcCtD
Pomalidomide—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00248	0.02	CcSEcCtD
Pomalidomide—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00247	0.02	CcSEcCtD
Pomalidomide—Skin disorder—Metformin—polycystic ovary syndrome	0.00245	0.0198	CcSEcCtD
Pomalidomide—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00244	0.0197	CcSEcCtD
Pomalidomide—ABCB1—adrenal gland—polycystic ovary syndrome	0.0023	0.00667	CbGeAlD
Pomalidomide—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.0023	0.0186	CcSEcCtD
Pomalidomide—Dyspnoea—Metformin—polycystic ovary syndrome	0.00225	0.0182	CcSEcCtD
Pomalidomide—Decreased appetite—Metformin—polycystic ovary syndrome	0.00219	0.0177	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00218	0.0176	CcSEcCtD
Pomalidomide—Fatigue—Metformin—polycystic ovary syndrome	0.00218	0.0176	CcSEcCtD
Pomalidomide—Constipation—Metformin—polycystic ovary syndrome	0.00216	0.0175	CcSEcCtD
Pomalidomide—ABCB1—female gonad—polycystic ovary syndrome	0.00215	0.00622	CbGeAlD
Pomalidomide—ABCB1—vagina—polycystic ovary syndrome	0.00213	0.00618	CbGeAlD
Pomalidomide—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00208	0.0168	CcSEcCtD
Pomalidomide—ABCB1—endocrine gland—polycystic ovary syndrome	0.002	0.00579	CbGeAlD
Pomalidomide—Asthenia—Metformin—polycystic ovary syndrome	0.00181	0.0146	CcSEcCtD
Pomalidomide—Pruritus—Metformin—polycystic ovary syndrome	0.00179	0.0144	CcSEcCtD
Pomalidomide—Diarrhoea—Metformin—polycystic ovary syndrome	0.00173	0.014	CcSEcCtD
Pomalidomide—Dizziness—Metformin—polycystic ovary syndrome	0.00167	0.0135	CcSEcCtD
Pomalidomide—Vomiting—Metformin—polycystic ovary syndrome	0.0016	0.013	CcSEcCtD
Pomalidomide—Rash—Metformin—polycystic ovary syndrome	0.00159	0.0129	CcSEcCtD
Pomalidomide—Dermatitis—Metformin—polycystic ovary syndrome	0.00159	0.0129	CcSEcCtD
Pomalidomide—Headache—Metformin—polycystic ovary syndrome	0.00158	0.0128	CcSEcCtD
Pomalidomide—Nausea—Metformin—polycystic ovary syndrome	0.0015	0.0121	CcSEcCtD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000412	0.000786	CbGpPWpGaD
Pomalidomide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000412	0.000784	CbGpPWpGaD
Pomalidomide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000409	0.00078	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000408	0.000778	CbGpPWpGaD
Pomalidomide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000404	0.000769	CbGpPWpGaD
Pomalidomide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000395	0.000753	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—DLG4—polycystic ovary syndrome	0.000395	0.000753	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.000392	0.000747	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000388	0.00074	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000385	0.000734	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000381	0.000727	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.00038	0.000723	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000376	0.000716	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000371	0.000707	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00037	0.000705	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000361	0.000688	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00036	0.000685	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000359	0.000683	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000358	0.000682	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000355	0.000676	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000353	0.000673	CbGpPWpGaD
Pomalidomide—TNF—TNF alpha Signaling Pathway—IL6—polycystic ovary syndrome	0.000349	0.000664	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000339	0.000645	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000335	0.000639	CbGpPWpGaD
Pomalidomide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000332	0.000632	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000331	0.00063	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000331	0.00063	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.00033	0.00063	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000326	0.000621	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000326	0.000621	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SUOX—polycystic ovary syndrome	0.000325	0.000618	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000325	0.000618	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—IL6—polycystic ovary syndrome	0.000321	0.000612	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000321	0.000611	CbGpPWpGaD
Pomalidomide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000321	0.000611	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000317	0.000605	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000307	0.000585	CbGpPWpGaD
Pomalidomide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000305	0.000581	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000302	0.000575	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000297	0.000566	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000296	0.000564	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000295	0.000562	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000293	0.000558	CbGpPWpGaD
Pomalidomide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	0.000288	0.000549	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—IL6—polycystic ovary syndrome	0.000286	0.000544	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000283	0.00054	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000281	0.000535	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000279	0.000532	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000277	0.000527	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000276	0.000526	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000275	0.000525	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000273	0.000521	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000272	0.000519	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.00027	0.000515	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000266	0.000507	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—IL6—polycystic ovary syndrome	0.000264	0.000504	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000261	0.000498	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000259	0.000493	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000257	0.000489	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—TEAD2—polycystic ovary syndrome	0.000257	0.000489	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000252	0.000479	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—IL6—polycystic ovary syndrome	0.000251	0.000477	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	0.00025	0.000476	CbGpPWpGaD
Pomalidomide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000247	0.000471	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000247	0.000471	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000247	0.00047	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—LEP—polycystic ovary syndrome	0.000243	0.000464	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000243	0.000463	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000232	0.000443	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	0.00023	0.000438	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	0.00023	0.000438	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000229	0.000435	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000228	0.000435	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000225	0.000429	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000223	0.000426	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000219	0.000416	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—RPL37A—polycystic ovary syndrome	0.000218	0.000416	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000216	0.000411	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000215	0.00041	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000214	0.000408	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—PPARG—polycystic ovary syndrome	0.000212	0.000404	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00021	0.0004	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—INS—polycystic ovary syndrome	0.000208	0.000396	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HMMR—polycystic ovary syndrome	0.000207	0.000394	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000204	0.000388	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—AKT2—polycystic ovary syndrome	0.000201	0.000383	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000201	0.000383	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—STAR—polycystic ovary syndrome	0.000194	0.00037	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000192	0.000366	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000192	0.000365	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000189	0.000359	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000187	0.000357	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	0.000184	0.00035	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000184	0.00035	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	0.000182	0.000347	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000182	0.000347	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000181	0.000346	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL6—polycystic ovary syndrome	0.000177	0.000337	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000176	0.000336	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000174	0.000331	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000174	0.000331	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—HMMR—polycystic ovary syndrome	0.000173	0.00033	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000171	0.000325	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—AKR1C1—polycystic ovary syndrome	0.00017	0.000325	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	0.00017	0.000324	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000167	0.000318	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000165	0.000315	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000165	0.000314	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000163	0.000311	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000162	0.000309	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—FGF18—polycystic ovary syndrome	0.000158	0.000301	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—RBP4—polycystic ovary syndrome	0.000157	0.000299	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000156	0.000297	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000155	0.000295	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000155	0.000295	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000152	0.00029	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—LHB—polycystic ovary syndrome	0.000151	0.000287	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000151	0.000287	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000148	0.000282	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000147	0.000281	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000145	0.000277	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	0.000145	0.000277	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000145	0.000275	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—GAB1—polycystic ovary syndrome	0.000144	0.000275	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000143	0.000272	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000142	0.00027	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000142	0.00027	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NAMPT—polycystic ovary syndrome	0.000141	0.000268	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.00014	0.000266	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—STAR—polycystic ovary syndrome	0.000138	0.000263	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000138	0.000263	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000137	0.000262	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000132	0.000251	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000131	0.00025	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000131	0.00025	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000131	0.00025	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	0.000131	0.00025	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	0.000129	0.000246	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	0.000127	0.000242	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000123	0.000235	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	0.000123	0.000234	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	0.000123	0.000234	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000122	0.000232	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	0.000118	0.000224	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000117	0.000223	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000117	0.000223	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000116	0.000222	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000116	0.00022	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000116	0.00022	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000115	0.00022	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000112	0.000213	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000112	0.000213	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	0.000111	0.000211	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	0.00011	0.00021	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	0.00011	0.000209	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000109	0.000207	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	0.000109	0.000207	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000108	0.000206	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—LHB—polycystic ovary syndrome	0.000107	0.000204	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000104	0.000199	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PRL—polycystic ovary syndrome	0.000104	0.000198	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000101	0.000193	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	9.81e-05	0.000187	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	9.39e-05	0.000179	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—TH—polycystic ovary syndrome	9.36e-05	0.000178	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	9.36e-05	0.000178	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	9.31e-05	0.000177	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	9.25e-05	0.000176	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	9.11e-05	0.000173	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—IL6—polycystic ovary syndrome	9.09e-05	0.000173	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	9.02e-05	0.000172	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	8.9e-05	0.00017	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	8.77e-05	0.000167	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	8.69e-05	0.000166	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NCOR1—polycystic ovary syndrome	8.69e-05	0.000166	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	8.56e-05	0.000163	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	8.53e-05	0.000163	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NRG1—polycystic ovary syndrome	8.53e-05	0.000163	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	8.49e-05	0.000162	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	8.35e-05	0.000159	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	8.34e-05	0.000159	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	8.25e-05	0.000157	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	8.08e-05	0.000154	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	7.79e-05	0.000148	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MTHFR—polycystic ovary syndrome	7.68e-05	0.000146	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	7.67e-05	0.000146	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	7.64e-05	0.000146	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	7.57e-05	0.000144	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	7.43e-05	0.000142	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IRS2—polycystic ovary syndrome	7.31e-05	0.000139	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	7.28e-05	0.000139	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	7.22e-05	0.000138	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	7.2e-05	0.000137	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	6.94e-05	0.000132	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	6.9e-05	0.000131	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	6.67e-05	0.000127	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—TH—polycystic ovary syndrome	6.64e-05	0.000126	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.63e-05	0.000126	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	6.59e-05	0.000125	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	6.58e-05	0.000125	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.54e-05	0.000125	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	6.45e-05	0.000123	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	6.44e-05	0.000123	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	6.43e-05	0.000123	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IRS1—polycystic ovary syndrome	6.38e-05	0.000122	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	6.23e-05	0.000119	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	6.22e-05	0.000118	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	6.12e-05	0.000117	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—INS—polycystic ovary syndrome	6.11e-05	0.000116	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	6.07e-05	0.000116	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—AKT2—polycystic ovary syndrome	5.91e-05	0.000112	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	5.74e-05	0.000109	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	5.61e-05	0.000107	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	5.56e-05	0.000106	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	5.42e-05	0.000103	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	5.36e-05	0.000102	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—TH—polycystic ovary syndrome	5.3e-05	0.000101	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	5.22e-05	9.94e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	5.16e-05	9.83e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	5.15e-05	9.82e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	5.15e-05	9.8e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—POMC—polycystic ovary syndrome	5.14e-05	9.8e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—INS—polycystic ovary syndrome	5.12e-05	9.75e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	5.08e-05	9.68e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	4.89e-05	9.32e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	4.84e-05	9.23e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	4.8e-05	9.14e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	4.72e-05	9e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	4.56e-05	8.69e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	4.32e-05	8.24e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	4.12e-05	7.85e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—TH—polycystic ovary syndrome	4.09e-05	7.79e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	3.98e-05	7.58e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	3.9e-05	7.44e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	3.74e-05	7.12e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	3.7e-05	7.04e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—POMC—polycystic ovary syndrome	3.65e-05	6.95e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	3.64e-05	6.94e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—INS—polycystic ovary syndrome	3.63e-05	6.91e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	3.34e-05	6.36e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.18e-05	6.06e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.01e-05	5.74e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	2.95e-05	5.62e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	2.91e-05	5.55e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—INS—polycystic ovary syndrome	2.9e-05	5.52e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.81e-05	5.35e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IL6—polycystic ovary syndrome	2.67e-05	5.09e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.28e-05	4.34e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.25e-05	4.28e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.23e-05	4.26e-05	CbGpPWpGaD
